Effect of Individualized Nursing Care on Diabetes Self-Management
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Yalova
About this trial
This randomized controlled trial aims to evaluate the effects of individualized nursing care interventions on self-efficacy, empowerment, and self-management behaviors in individuals diagnosed with diabetes. Diabetes requires lifelong management, and standard care approaches often fall short of meeting individual psychosocial and clinical needs. By implementing structured, patient-centered nursing care protocols, this study assesses how personalized education, follow-up, and support mechanisms influence patients' capacity to manage their condition, improve glycemic control, and enhance their overall quality of life.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosed with diabetes (Type 1 or Type 2)
Age 18 years or older
Able to communicate in Turkish and cooperate with the study requirements
Voluntarily willing to participate and sign the informed consent form
Disqualifiers
Having severe cognitive impairment, psychiatric disorders, or communication barriers that prevent participation
Having severe terminal illnesses or acute medical complications that interfere with follow-up
Trial design
Design model
Parallel
Treatments tested in this trial
Individualized Nursing Care
BehavioralParticipants in this group receive structured, personalized nursing care sessions, including targeted education, individual goal-setting, self-monitoring guidance, and ongoing follow-up to enhance diabetes self-management.
Treatment groups
68 Participants
are divided into 2 treatment groupsGroup A: Intervention Group (Arm 1)Experimental treatment 1 intervention
Group B: Control Group (Arm 2)No intervention 0 interventions
Trial outcomes
Primary outcomes
1
Adult Diabetes Knowledge Score
Change in adult diabetes knowledge score as measured by the Adult Diabetes Knowledge Scale (ADKS) from baseline to 3 months. (Total score ranging from 0 to 28 points).
Time frame
Baseline and 3 months2
Diabetes Self-Management Behaviors Score
Change in diabetes self-management score as measured by the Diabetes Self-Management Questionnaire (DSMQ) from baseline to 3 months. (Total and subscale points).
Time frame
Baseline and 3 months3
Diabetes Empowerment and Psychosocial Self-Efficacy Score
Change in diabetes empowerment score as measured by the Diabetes Empowerment Scale (DES) from baseline to 3 months. (Likert scale points ranging from 0 to 5).
Time frame
Baseline and 3 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Yalova
Lead sponsor
Yalova training and research hospital
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: